A look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.
Erica Smith, PhD
Advertisement
Articles by Erica Smith, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How IQVIA and Veeva Are Improving Efficiency and Data Management in Clinical Trials
2
Operational Challenges of Using Overall Survival as a Primary Endpoint
3
ACT Brief Weekly Recap: Partnerships, Site Networks, and AI Reshaping Clinical Trials
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
